CURRICULUM VITAE

Petrescu Bogdan Mircea

Pregătire profesională
 2000-2006- Universitatea de Medicină şi Farmacie "Carol Davila" Bucureşti, Facultatea
Medicină Generală , Licenta 2006
 2013- Medic specialist psihiatru
 2017 - Medic primar psihiatru
 2016-2022- Doctorat in Stiinte Medicale, Universitatea de Medicină şi Farmacie
"Carol Davila" Bucureşti, Facultatea Medicină Generală-coordonator Prof Habil Dr Sorin
Riga

Funcții ocupate
 2017- prezent , Medic primar psihiatru Spitalul Universitar de Urgenţă Militar Central "Dr.
Carol Davila", Bucuresti, www.scumc.ro
 2013-2017 Medic specialist psihiatru Spitalul Universitar de Urgenţă Militar Central "Dr.
Carol Davila",Bucuresti,www.scumc.ro
 2012-2013 Medic rezident psihiatru Spitalul Universitar de Urgenţă Militar Central "Dr.
Carol Davila" Bucuresti
 2011-2012 Medic rezident psihiatru Little Book Hospital, Dartford, Kent and Medway nhs
trust, Anglia Assertive Outreach Team, Derby, Derbyshire health care foundation NHS
trust, Anglia
 2010-2011 Medic rezident psihiatru Spitalul Clinic de Psihiatrie ”Al Obregia” Bucuresti
 2009-2010 Medic rezident psihiatru Spitalul Universitar de Urgenţă Militar Central "Dr.
Carol Davila" Bucuresti
 2007-2008 Medic rezident psihiatru Spitalul Clinic de Psihiatrie ”Al Obregia” Bucuresti
 2006-2007 Medic rezident medicina de familie Spitalul Universitar de Urgenţă Militar
Central "Dr. Carol Davila" Bucuresti

Participări la congrese naţionale şi internaţionale cu tematică medical

1
  Exercitiul Multinational "medceur / rescue" – Septembrie 2005 Tbilisi, Georgia;
 Conferinta Nationala de Medicina de Familie– Martie 2007 Bucuresti
 Al 8lea congres national de medicina interna, Aprilie 2007 Calimanesti - Caciulata Al 9lea
congres national de medicina interna, Aprilie 2008 Calimanesti Caciulata
 Simpozionul “Directii in psihiatria comunitara ” Mai 2008 Timisoara Curs de hipnoza clinica
psihoterapie Ericksoniana 2008
 Conferinta International de Psihiatrie romano-ungara, iunie 2008 Miercurea Ciuc Conferinta
Nationala de psihiatrie biologica and psihofarmacologie Martie 2010 Craiova
 “Zilele Spitalului Universitar de Urgenta Militar Central”, septembrie 2014 Bucuresti
 27th ECNP Congress, 18-21 October 2014, Berlin, Germany
 “Zilele Spitalului Universitar de Urgenta Militar Central”, septembrie 2015 Bucuresti
 28th ECNP Congress, 29 August-1 September 2015, Amsterdam, The Netherlands
 1st Eastern European Conference Of Mental Ealth “In And Out Of Your Mind”, Galati 2017
 Central European Schizophrenia Meeting, 29-30 Jun 2018 Bucharest
 31st ECNP Congress, 6-9 October 2018, Barcelona, Spain
 32nd ECNP Congress 7-10 september 2019, Copenhaga
 Conferinta nationala de psihiatrie No Addict 2023,”Inovatie si perspective in sanatatea mintala
si medicina adictiei”, 04-06 mai 2023
 18th European Congress of Psychiatry, February 27-march 2, 2010, Munich, Germany.

Lucrări indexate Clarivate - Web of Science - în rezumat

-Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Petrescu BM, Nastase DM, Bogdan
V. Quality of life improvement through depression treatment in oncologic patients. 18th European
Congress of Psychiatry. European Psychiatry 2010;25(Suppl.1):997. https://doi.org/10.1016/S0924-
9338(10)70987-1.
-Vasile D, Vasiliu O, Bogdan V, Badescu E, Mangalagiu AG, Stanescu B, Petrescu BM. The
efficacy of psychopharmacologic treatment in depressive disorder associated with Parkinson’s disease
dementia. 18th European Congress of Psychiatry. European Psychiatry 2010;25(Suppl.1):996.
https://doi.org/10.1016/S0924-9338(10)70986-X.
-Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Badescu E, Petrescu BM, Bogdan V, Ojog DG.
The influence of the conflicting paradigms over the prognosis in major depressive disorder. 18th European
Congress of Psychiatry. European Psychiatry 2010;25(Suppl.1):224. https://doi.org/10.1016/S0924-

2
9338(10)70224-8.
-Vasile D, Vasiliu O, Vasile ML, Mangalagiu AG, Stanescu B, Terpan M, Nastase DM, Petrescu
BM, Bogdan V. Treatment strategies for the management of the self-aggressive manifestations in heroin
dependence. 18th European Congress of Psychiatry. European Psychiatry 2010;25(Suppl.1):1667.
https://doi.org/10.1016/S0924-9338(10)71656-4.
-Vasile D, Vasiliu O, Mangalagiu AG, Vasile ML, Badescu E, Bogdan V, Terpan M, Ojog DG,
Petrescu BM. Addressing self-image distortions as a core feature in the alcohol dependence
psychotherapeutic approach. 18th European Congress of Psychiatry. European Psychiatry
2010;25(Suppl.1):1678. https://doi.org/10.1016/S0924-9338(10)71657-6.
-Vasile D, Vasiliu O, Tudor C, Vasile ML, Grigorescu G, Bogdan V, Terpan M, Mangalagiu AG,
Petrescu MB, Ojog D. Galantamine switch in donepezil non-responsive patients with early-onset
Alzheimer dementia. XXVII CINP Congress. International Journal of Neuropsychopharmacology
2010;13:141
-Vasile D, Vasiliu O, Vasile ML, Terpan M, Mangalagiu A, Bogdan V, Ojog D, Petrescu MB,
Paraico I. Influences between defense mechanisms and antidepressants on the therapeutic compliance in
major depressive disorder. 23rd ECNP Congress. European Neuropsychopharmacology 2010;20:S343-
S344. https://doi.org/10.1016/S0924-977X(10)70474-0.
-Vasile D, Vasiliu O, Vasile ML, Terpan M, Grigorescu G, Bogdan V, Mangalagiu A, Petrescu MB,
Ojog D. Comparative efficacy of cholinesterase inhibitors in dementia associated with Parkinson’s disease.
23rd ECNP Congress. European Neuropsychopharmacology 2010;20:S553-S554.
https://doi.org/10.1016/S0924-977X(10)70834-8.
-Vasile D, Vasiliu O, Tudor C, Mangalagiu AG, Petrescu BM, Sopterean GA, Bratu RE.
Pharmacological management of alcohol dependence in chronic schizophrenia. 26th ECNP Congress.
European Neuropsychopharmacology 2013;23(Suppl.2):S429. https://doi.org/10.1016/S0924-
977X(13)70679-5.
-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM. Characteristics of the antipsychotic switch to
amisulpride in schizophrenia in Romanian practice- a multicentric, retrospective data collection (SWITCH
study). 21st European Congress of Psychiatry. European Psychiatry 2013;28(1):1125.
https://doi.org/10.1016/S0924-9338(13)76227-8.
-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM. A multicentric, retrospective data collection
from patients diagnosed with schizophrenia switched to Solian® in Romanian practice- SWITCH study.
21st European Congress of Psychiatry. European Psychiatry 2013;28(1):1124.
https://doi.org/10.1016/S0924-9338(13)76226-6.
3
 -Petrescu B, Vasile D, Vasiliu O, Tudor C, Mangalagiu A, Ungureanu D. SSRI dose escalation
versus duloxetine in treatment of major depressive disorder not responding to initial SSRI. 27th ECNP
Congress. European Neuropsychopharmacology 2014;24(2):S455-456. https://doi.org/10.1016/S0924-
977X(14)70729-1.
-Petrescu B, Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D. A comparative
prospective study of agomelatine versus escitalopram in treatment of severe major depressive disorder.
28th ECNP Congress. European Neuropsychopharmacology 2015;25(Suppl.2):S439.
https://doi.org/10.1016/S0924-977X(15)30588-5.
-Petrescu B, Vasile D, Vasiliu O, Mangalagiu A, Riga D, Riga S, Mitrache A, Simioniuc-Petrescu
A. Evaluation of trazodone and quetiapine in patients with Alzheimer’s type dementia and sleep
disturbance. 31st ECNP Congress. European Neuropsychopharmacology 2019;29(Suppl.1):S156.
https://doi.org/10.1016/j.euroneuro.2018.11.274.
-Petrescu B, Vasile D, Vasiliu O, Mangalagiu A, Candea C, Riga D, Riga S, Mitrache A.
Management of psychosis with quetiapine in Alzheimer type dementia and Parkinson type dementia. 32nd
ECNP Congress. European Neuropsychopharmacology 2019 ;29(6):S134.
-Petrescu B, Vasile D, Vasiliu O, Mangalagiu A, Candea C, Riga S. Sodium valproate and
lamotrigine- options in the treatment of behavioral and psychological symptoms of probable Alzheimer’s
disease and vascular dementia. 33rd ECNP Congress. European Neuropsychopharmacology
2020;40(Suppl.1):S221-222. https://doi.org/10.1016/j.euroneuro.2020.09.289.
-Vasiliu O, Vasile D, Voicu VA, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C, Vasiliu DG,
Ungureanu D, Fainarea AF, Stanescu RDA, Manolache RE, Alexandru IA, Ghenoiu IE, Lecu RA, Gionea
M, Gainaru F, Vlaicu RG, Amanolesei I. Calcium channel alpha-2-delta ligands as add-on strategy to
antidepressants in generalized anxiety disorder and major depressive disorder dual diagnosis. 33rd ECNP
Congress. European Neuropsychopharmacology 2020;40(Suppl.1):S372-353.
https://doi.org/10.1016/j.euroneuro.2020.09.482.
-Vasile D, Vasiliu O, Mangalagiu A, Petrescu B, Tudor C, Candea C. Mindfulness-based cognitive
therapy for major depressive disorder- a literature review. 29th European Congress of Psychiatry.
European Psychiatry 2021;64(Suppl.1):S494. doi: 10.1192/j.eurpsy.2021.1320.
-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C, Bratu-Bizic RE,
Fainarea AF, Patrascu MC. Cannabinoids in the therapeutic management of mood disorders. P73. 25th
ISBD Conference. Bipolar Disorders 2023;25(S1):82.
-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BP, Candea CA, Tudor C, Ungureanu D, Miclos
M, Florescu C, Draghici A, Bratu-Bizic RE, Dobre M, Fainarea AF, Patrascu MC. Therapeutic challenges
4
in case of dual diagnosis-cannabis use disorder and bipolar disorder. P85. 25th ISBD Conference. Bipolar
Disorders 2023;25(S1):86.
-Vasiliu O, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C, Ungureanu D, Miclos M,
Florescu C, Draghici AI, Bratu-Bizic RE, Dobre M, Fainarea AF, Patrascu MC. Next-generation
antipsychotics- Trends and perspectives beyond dopaminergic and glutamatergic agents. 31st European
Congress of Psychiatry. European Psychiatry 2023;66(S1):S558-559. doi: 10.1192/j.eurpsy.2023.1177.

Lucrări in-extenso indexate Clarivate - Web of Science Core Collection cu factor de impact
-Vasiliu O, Mangalagiu AG, Petrescu BM, Cândea CA, Tudor C, Vasile D. Analysis of COVID-
19-related psychiatric disorders- clinical manifestations and therapeutic considerations. RJMM
2022;3(CXXV):382-391. doi: 10.55453/rjmm.2022.125.3.5.
-Mangalagiu AG, Riga S, Vasiliu O, Petrescu BM. Stress and pathogenesis of major depressive
disorder. A narrative review. Intl J Med Dent 2021;25(1):24-35.
-Petrescu BM, Riga S, Vasiliu O, Mangalagiu AG. Key targets of tau-oriented therapeutic
interventions for neurodegenerative diseases. Intl J Med Dent 2021;25(1):74-84.
-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu MB, Candea CA, Tudor C, Ungureanu D, Miclos
M, Draghici A, Florescu C, Bratu-Bazic R. Current treatment of posttraumatic stress disorder- A review of
therapeutic guidelines and good practice recommendations. RJMM 2020;CXXIII(4):241-248.
-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Tudor C, Ungureanu D, Candea C. Efficacy
and tolerability of calcium channel alpha-2-delta ligands in psychiatric disorders. RJMM 2017;CXX(2):27-
31.
-Vasile D, Vasiliu O, Mangalagiu AG, Vasile ML, Grigorescu G, Vasile B, Terpan M, Petrescu BM,
Năstase DM. Defense mechanisms evaluation of the double diagnosis- fibromyalgia and mixed anxiety-
depressive disorder diagnosis. RJMM 2010;2(CXIII):43-47
-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Stănescu B, Năstase DM. Psychotic disorders
due to psychotropic drugs. RJMM 2009;3(CXII):33-38.

Articole in extenso publicate în reviste de specialitate indexate BDI

-Petrescu BM, Riga S, Vasiliu O, Mangalagiu AM. Physical activity and maintaining of the
proteome in the aging process- are these footsteps on the way to longevity? Health, Sports &
Rehabilitation Medicine 2021;22(2):120-26. https://doi.org/10.26659/pm3.2021.22.2.120.
-Petrescu BM, Riga S. Management of neuropsychiatric symptoms in people with neurocognitive

5
disorder - using add-on antidepressants or NMDA antagonists in relieving agitation. Original Study.
Health, Sports & Rehabilitation Medicine 2021;22(4):202–209.
https://doi.org/10.26659/pm3.2021.22.4.202.

Lucrări prezentate la congrese și conferințe naționale și internaționale, publicate în volume

de rezumate, programul manifestărilor științifice respective sau în reviste de specialitate indexate
BDI

-Vasile D, Vasiliu O, Taina NF, Mangalagiu AG, Petrescu B, Blandu M, Ojog DG. Quality of life
assessment in colon malignant tumors asssociated depression during trazodone treatment. 13th
International Congress of the Romanian Society of Pharmacology, Therapeutics and Clinical Toxicology,
2012. Abstract Book p.12

-Vasile D, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D, Petrescu BM, Bogdan V,

Grigorescu G, Blandu M. Diagnosticul multiaxial în tulburările somatoforme. Zilele Spitalului Universitar
de Urgență Militar Central „Dr.Carol Davila”, 2012, Volum de rezumate

-Vasile D, Vasiliu O, Mangalagiu AG, Blandu M, Petrescu BM. Newly diagnosed Alzheimer
Dementia cases in non-psychiatric departments of a general medical hospital- a liaison psychiatry study.
Romanian Journal of Psychiatry 2013;XV(Suppl.1):P-69

-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Blandu M. Analysis of the organic
comorbidities in early-onset Alzheimer Dementia patients. Romanian Journal of Psychiatry
2013;XV(Suppl.1):OC-01

-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Taina NF. Combined naltrexone and cognitive
therapy in binge drinking patients with cluster B personality features. P-17-014. 11th World Congress of
Biological Psychiatry 2013

-Vasile D, Vasiliu O, Petrescu MB. Efficacy of rivastigmine patch in mixed severe neurocognitive
disorders. Zilele Spitalului Universitar de Urgență Militar Central “Dr. Carol Davila”, 2014, Programul
final

-Vasile D, Petrescu BM, Vasiliu O, Mangalagiu A, Candea C. Delirium and depression:

relationship and clinical overlap in elderly people. Abstracts of 20th Congress of Balkan Military Medical
Committee. Balkan Military Medical Review 2015;18(5):e77.

-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Tudor C, Candea C, Bazac-Bratu RE,

6
Androne FT, Alboaie AF, Patrascu M, Patrascu EA. Improving treatment adherence in schizophrenia
diagnosed patients by using long acting injectable antipsychotics. Carol Davila University Central
Emergency Military Hospital Scientific Days, 6th Ed. Romanian Journal of Military Medicine 2016;
vol.CXIX(Suppl.):5

-Candea C, Vasile D, Vasiliu O, Petrescu B, Mangalagiu A, Candea I, Badic AM. Psychiatry and
terrorism. Carol Davila University Central Emergency Military Hospital Scientific Days, 6th Ed.
Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):30

-Candea C, Vasile D, Vasiliu O, Petrescu B, Mangalagiu A, Candea I, Badic AM. Transcultural

psychiatry. Carol Davila University Central Emergency Military Hospital Scientific Days, 6th Ed.
Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):30

-Vasile D, Vasiliu O, Petrescu MB. Efficacy of rivastigmine patch in mixed severe neurocognitive
disorders. Zilele Spitalului Universitar de Urgență Militar Central “Dr. Carol Davila”, 2014, Programul
final

-Petrescu BM, Vasile D, Vasiliu O, Mangalagiu A, Candea C. Borderline personality disorder- a

challenging diagnosis. 22nd Congress of the Balkan Military Medical Committee, 2017; OP30.

-Badic M, Vasile D, Vasiliu O, Petrescu BM, Candea CA. Is there a different prevalence of
depression among the military and the general active population? 22nd Congress of the Balkan Military
Medical Committee, 2017; OP157.

-Petrescu BM, Mitrache A, Vasile D, Vasiliu O, Mangalagiu AG, Candea CA. Prescribing
anticholinergic drugs in neurocognitive disorders: pharmacological implications and clinical evidence.
Abstracts of the 1st Eastern European Conference of Mental Health. American Journal of Psychiatry and
Neuroscience 2017;5(6-1):14

-Petrescu BM, Vasile D, Vasiliu O, Mangalagiu AG, Badic MA. The psychophysiological effects
of chemical terrorist attacks- the sarin neurotoxic agent. Abstracts of the 1st Eastern European Conference
of Mental Health. American Journal of Psychiatry and Neuroscience 2017;5(6-1):15

-Vasile D, Vasiliu O, Petrescu BM, Badic AM, Mangalagiu AG, Tudor C, Candea CA. New
pharmacological approaches in obesity. The 10th National Conference of Biological Psychiatry and
Psychopharmacology. Romanian Journal of Psychopharmacology 2017;17(1):O06

-Vasile D, Vasiliu O, Badic AM, Petrescu BM, Candea CA, Tudor C, Mangalagiu AG. Quality of
life assessment during pharmacological treatment in patients with schizophrenia. The 10th National
7
Conference of Biological Psychiatry and Psychopharmacology. Romanian Journal of
Psychopharmacology 2017;17(1):O15

-Vasile D, Vasiliu O, Petrescu BM, Candea CA, Androne F, Fainarea AF, Patrascu M, Morariu EA.
Recommendations for long acting injectable antipsychotics in patients with schizophrenia. The 10th
National Conference of Biological Psychiatry and Psychopharmacology. Romanian Journal of
Psychopharmacology 2017;17(1):O16

-Vasiliu O, Vasile D, Badic A, Petrescu BM, Candea CA. Personalized medicine and
psychopharmacogenomics. The 10th National Conference of Biological Psychiatry and
Psychopharmacology. Romanian Journal of Psychopharmacology 2017;17(1):O21

-Vasiliu O, Vasile D, Petrescu BM, Badic A, Candea CA. Augmenting selective serotonin reuptake
inhibitors in case of partial response in patients with major depressive disorder. The 10th National
Conference of Biological Psychiatry and Psychopharmacology. Romanian Journal of
Psychopharmacology 2017;17(1):O22

-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu MB, Candea CA, Tudor C, Fainarea AF, Patrascu
MC, Morariu EA, Badic AM, Manolache RE, Alexandru IA. Pharmacological management of late-onset
schizophrenia- a case series. EP.1002. 31st ECNP Congress, 2018. Final Programme:113.
-Vasiliu O, Vasile D, Petrescu MB, Mangalagiu AG, Candea CA, Fainarea AF, Patrascu MC,
Morariu EA, Badic AM, Manolache RE, Alexandru IA. Combined pharmacological treatment for alcohol
dependence- review of current evidence and new study project. EP1003.31st ECNP Congress, 2018. Final
Programme:113.

-Vasile D, Vasiliu O, Mangalagiu AG, Petrescu BM, Tudor C, Candea CA, Ungureanu D.
Biological therapies for Alzheimer Dementia- the current status of clinical research and future trends.
EP1000. 31st ECNP Congress, 2018. Final Programme:113.

-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Candea C, Tudor C, Ungureanu D. Analysis
of organic and psychiatric comorbidities in patients with schizophrenia during antipsychotic treatment. A
XI-a Conferință Națională de Psihiatrie Biologică și Psihofarmacologie. Romanian Journal of Psychiatry
2018;XX(1):15

-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C, Ungureanu D, Miclos
M, Draghici A, Florescu C. Anti-inflammatory interventions in major depressive disorder: status of
research and therapeutic perspectives. Carol Davila University Central Emergency Military Hospital
Scientific Days, 9th Ed., Romanian Journal of Military Medicine 2019;CXXII (Suppl.1):10.
8
 -Vasiliu O, Sirbu CA, Dobrescu L, Vasile D, Mangalagiu AG, Petrescu BM, Tudor C, Candea C,
Ungureanu D, Miclos M, Draghici A, Florescu C. Advances in defining social network site addiction. 23rd
World Congress of Social Psychiatry, Bucharest, 2019, Abstract book 213.doi: 10.1159/000502323.

-Vasiliu O, Vasile D, Mangalagiu AG, Petrescu BM, Candea CA, Tudor C, et al. New treatments
for major neurocognitive disorder due to Alzheimer’s disease. Conferința Anuală a Spitalului Universitar
de Urgență Militar Central ”Dr. Carol Davila”, ediția a X-a. Romanian Journal of Military Medicine
2021;CXXIV(Suppl.1):23.
-Mangalagiu AG, Riga S, Vasiliu O, Petrescu BM, Vasile D, Mangalagiu D, Candea C. Stress and
anxious disorders- a neurobiological perspective. Congresul Național de Psihiatrie 2022, Volum de
rezumate științifice, p.22.
-Vasile D, Alexinschi OE, Vasiliu O, Bolos A, Gaina MA. Contemporary challenges in social
psychiatry- Interventions to improve mental health in refugees and migrants. Congresul Național de
Psihiatrie 2022, Volum de rezumate științifice, p.118.
-Vasiliu O, Mangalagiu AG, Petrescu BM, Cândea CA. Markerii biologici ai riscului suicidar-
actualități și perspective. Intervenția multidisciplinară în criză, București, Alianța Română pentru
Prevenția Suicidului, octombrie 2023, Programul conferinței, p.5

-Mangalagiu AG, Petrescu BM, Cândea CA, Vasiliu O, Tudor C, Vasile D. Managementul de caz
al suicidului asociat depresiei vârstnicului- abordări psihofarmacologice. Intervenția multidisciplinară în
criză, București, Alianța Română pentru Prevenția Suicidului, octombrie 2023, Programul conferinței, p.6

-Petrescu BM, Vasiliu O, Mangalagiu AG, Cândea CA. Psihofarmacologia comportamentului

suicidar- de la profilaxie la tratament. Intervenția multidisciplinară în criză, București, Alianța Română
pentru Prevenția Suicidului, octombrie 2023, Programul conferinței, p.6

-Cândea CA, Petrescu BM, Vasiliu O, Mangalagiu AG, Tudor C, Ungureanu D, Dobre M,
Florescu C, Miclos M, Draghici A, Bratu-Bizic RE, Fainarea AF, Patrascu MC, Vasile D. Analiza
transnosografică a riscului suicidar din perspectiva clinică și terapeutică- studii de caz. Intervenția
multidisciplinară în criză, București, Alianța Română pentru Prevenția Suicidului, octombrie 2023,
Programul conferinței, p.6

9
 Participare în studii farmacoclinice- subinvestigator (selectiv)
 ADAMANT- A 24-months randomized, placebo-controlled, parallel-group, double-blinded,
multicenter, phase 2 study to assess safety and efficacy of AADvac1 applied to patients with
mild Alzheimer’s disease. Protocol AC-AD-003, EudraCT 2015-000630-30. Phase II, 2016.
 A double-blind, placebo-controlled, randomized withdrawal, multicenter clinical trial evalu-
ating the efficacy, safety, and tolerability of cariprazine in a dose-reduction paradigm in the
prevention of relapse in bipolar I disorder patients whose current episode is manic or depres-
sive, with or without mixed features. Protocol RGH-MD-25, EudraCT 2017-000803-25.
Phase III, 2020-2021
 A randomized, double-blind, active comparator-controlled study to evaluate the long-term
safety and tolerability of SEP-363856 in subjects with schizophrenia. Protocol SEP361-304,
EudraCT 2019-002259-40. Phase III, 2020-2022.
 A Randomized, Double-Blind, Placebo-Controlled Study on Efficacy and Safety of TV-
44749 in Adults with Schizophrenia. NCT 05693935, EudraCT Number 2022-001865-11.
Phase III, 2023-
 A double-blind, placebo-controlled. Randomized withdrawal, multicenter clinical trial evalu-
ating the efficacy, safety, and tolerability of cariprazine in a dose-reduction paradigm in the
prevention of relapse in patients with schizophrenia. Protocol RGH-MD-24, EudraCT 2017-
00818-34. Phase III, 2020-2021
 A 26-week open-label safety and tolerability extension study of SEP-363856 in adult sub-
jects with schizophrenia. Protocol SEP361-202, EudraCT 2016-001556-21. Phase II, 2016-
2018.
 A phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicenter, fixed-
dose clinical trial evaluating the efficacy, safety, and tolerability of cariprazine in the preven-
tion of relapse in bipolar I disorder patients whose current or most recent episode is manic,
with or without mixed features. Protocol RGH-MD-53, EudraCT 2016-000756-98. Phase III,
2016-2018.

Premii/mențiuni obținute

Diplomă de excelență pentru participare cu lucrare științifică la conferința ”Psihiatria românească

între știință și practică. Respectarea drepturilor profesioniștilor din domeniul sănătății mintale”, București,
2019.

10
Limbi străine cunoscute
- engleza- nivel B2 conform Cadrului Comun European-CCE
- franceza- nivel B2 conform CCE

11